85 filings
Page 4 of 5
8-K
yru4f9 f1a
16 Aug 21
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2021 Results and Provides Business Update
4:11pm
10-Q
ofia8n ni
13 Aug 21
Quarterly report
4:06pm
S-8
l0btpzki4i v6ooqevo
19 Jul 21
Registration of securities for employees
5:27pm
8-K
hw5i qpx9kfjc5
29 Jun 21
ACURX PHARMACEUTICALS, INC. announces pricing of $15 Million
5:00pm
424B4
1cpnxz1x6 8o
28 Jun 21
Prospectus supplement with pricing info
6:02am
EFFECT
2t0a8qd5hcfkd9
25 Jun 21
Notice of effectiveness
12:15am
CERT
ktpdp3qt
24 Jun 21
Certification of approval for exchange listing
10:00am
8-A12B
kbg2kaz9
23 Jun 21
Registration of securities on exchange
4:06pm
CORRESP
u61wy4f2h0
22 Jun 21
Correspondence with SEC
12:00am
CORRESP
kq0 7llq13q8956f
22 Jun 21
Correspondence with SEC
12:00am
FWP
ai68cq4 einylpitb5x
11 Jun 21
Free writing prospectus
6:05am
S-1/A
j03b84ce33gfa
11 Jun 21
IPO registration (amended)
6:02am
S-1
uk4uawyfe p4
27 May 21
IPO registration
12:00am
CORRESP
9nm7sw
26 May 21
Correspondence with SEC
12:00am
UPLOAD
jl2x4uddt30qu lce3gd
21 May 21
Letter from SEC
12:00am
DRSLTR
znoetszecz29jn roru
10 May 21
Correspondence regarding draft registration statement
12:00am
DRS/A
verougn wesla
10 May 21
Draft registration statement (amended)
12:00am
UPLOAD
yh7sc
30 Apr 21
Letter from SEC
12:00am
DRS
wjzvs5b
5 Apr 21
Draft registration statement
12:00am